Melbourne, Australia, and LIÈGE, Belgium, Oct. 24, 2017 – Telix Pharmaceuticals (Telix) is pleased to announce that it has entered into a development and commercialisation partnership with Advanced Nuclear Medicine Ingredients SA (ANMI). To read the full release click here.